Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes.

Anguera MC, Sadreyev R, Zhang Z, Szanto A, Payer B, Sheridan SD, Kwok S, Haggarty SJ, Sur M, Alvarez J, Gimelbrant A, Mitalipova M, Kirby JE, Lee JT.

Cell Stem Cell. 2012 Jul 6;11(1):75-90. doi: 10.1016/j.stem.2012.03.008.

2.

Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells.

Tomoda K, Takahashi K, Leung K, Okada A, Narita M, Yamada NA, Eilertson KE, Tsang P, Baba S, White MP, Sami S, Srivastava D, Conklin BR, Panning B, Yamanaka S.

Cell Stem Cell. 2012 Jul 6;11(1):91-9. doi: 10.1016/j.stem.2012.05.019.

3.

Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cells.

Bruck T, Benvenisty N.

Stem Cell Res. 2011 Mar;6(2):187-93. doi: 10.1016/j.scr.2010.12.001.

4.

Erosion of dosage compensation impacts human iPSC disease modeling.

Mekhoubad S, Bock C, de Boer AS, Kiskinis E, Meissner A, Eggan K.

Cell Stem Cell. 2012 May 4;10(5):595-609. doi: 10.1016/j.stem.2012.02.014.

5.

X-chromosome epigenetic reprogramming in pluripotent stem cells via noncoding genes.

Kim DH, Jeon Y, Anguera MC, Lee JT.

Semin Cell Dev Biol. 2011 Jun;22(4):336-42. doi: 10.1016/j.semcdb.2011.02.025. Review.

6.

Xist deficiency and disorders of X-inactivation in rabbit embryonic stem cells can be rescued by transcription-factor-mediated conversion.

Jiang Y, Kou Z, Wu T, An W, Zhou R, Wang H, Gao Y, Gao S.

Stem Cells Dev. 2014 Oct 1;23(19):2283-96. doi: 10.1089/scd.2014.0011.

7.

A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability.

Burridge PW, Thompson S, Millrod MA, Weinberg S, Yuan X, Peters A, Mahairaki V, Koliatsos VE, Tung L, Zambidis ET.

PLoS One. 2011 Apr 8;6(4):e18293. doi: 10.1371/journal.pone.0018293.

8.

X-inactivation reveals epigenetic anomalies in most hESC but identifies sublines that initiate as expected.

Hall LL, Byron M, Butler J, Becker KA, Nelson A, Amit M, Itskovitz-Eldor J, Stein J, Stein G, Ware C, Lawrence JB.

J Cell Physiol. 2008 Aug;216(2):445-52. doi: 10.1002/jcp.21411.

9.

X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells.

Silva SS, Rowntree RK, Mekhoubad S, Lee JT.

Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4820-5. doi: 10.1073/pnas.0712136105.

10.

X chromosome inactivation and epigenetic responses to cellular reprogramming.

Lessing D, Anguera MC, Lee JT.

Annu Rev Genomics Hum Genet. 2013;14:85-110. doi: 10.1146/annurev-genom-091212-153530. Review.

PMID:
23662665
11.

Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells.

Ghosh Z, Wilson KD, Wu Y, Hu S, Quertermous T, Wu JC.

PLoS One. 2010 Feb 1;5(2):e8975. doi: 10.1371/journal.pone.0008975.

12.

Gene and MicroRNA Profiling of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells.

Wang L, Su W, Du W, Xu Y, Wang L, Kong D, Han Z, Zheng G, Li Z.

Stem Cell Rev. 2015 Apr;11(2):219-27. doi: 10.1007/s12015-014-9582-4.

PMID:
25618294
13.

XIST RNA and architecture of the inactive X chromosome: implications for the repeat genome.

Hall LL, Lawrence JB.

Cold Spring Harb Symp Quant Biol. 2010;75:345-56. doi: 10.1101/sqb.2010.75.030. Review.

14.

Aberrant patterns of X chromosome inactivation in a new line of human embryonic stem cells established in physiological oxygen concentrations.

de Oliveira Georges JA, Vergani N, Fonseca SA, Fraga AM, de Mello JC, Albuquerque MC, Fujihara LS, Pereira LV.

Stem Cell Rev. 2014 Aug;10(4):472-9. doi: 10.1007/s12015-014-9505-4.

PMID:
24633531
15.

Progressive accumulation of epigenetic heterogeneity during human ES cell culture.

Tanasijevic B, Dai B, Ezashi T, Livingston K, Roberts RM, Rasmussen TP.

Epigenetics. 2009 Jul 1;4(5):330-8.

PMID:
19571681
16.

Suppression of the imprinted gene NNAT and X-chromosome gene activation in isogenic human iPS cells.

Teichroeb JH, Betts DH, Vaziri H.

PLoS One. 2011;6(10):e23436. doi: 10.1371/journal.pone.0023436.

17.

X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations.

Shen Y, Matsuno Y, Fouse SD, Rao N, Root S, Xu R, Pellegrini M, Riggs AD, Fan G.

Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4709-14. doi: 10.1073/pnas.0712018105.

18.

Reactivation of the inactive X chromosome and post-transcriptional reprogramming of Xist in iPSCs.

Kim JS, Choi HW, Araúzo-Bravo MJ, Schöler HR, Do JT.

J Cell Sci. 2015 Jan 1;128(1):81-7. doi: 10.1242/jcs.154294.

19.

Ftx is a non-coding RNA which affects Xist expression and chromatin structure within the X-inactivation center region.

Chureau C, Chantalat S, Romito A, Galvani A, Duret L, Avner P, Rougeulle C.

Hum Mol Genet. 2011 Feb 15;20(4):705-18. doi: 10.1093/hmg/ddq516.

PMID:
21118898
20.

Stability of genomic imprinting in human induced pluripotent stem cells.

Hiura H, Toyoda M, Okae H, Sakurai M, Miyauchi N, Sato A, Kiyokawa N, Okita H, Miyagawa Y, Akutsu H, Nishino K, Umezawa A, Arima T.

BMC Genet. 2013 Apr 30;14:32. doi: 10.1186/1471-2156-14-32.

Supplemental Content

Support Center